NSE BSE
metropolis healthcare ltd stock

METROPOLIS HEALTHCARE LTD Share Price

- - (%)
Sector: -

9581

542650

METROPOLIS

img img img img
No Data Available

METROPOLIS HEALTHCARE LTD : Share Price Update


As of the latest trading session, METROPOLIS HEALTHCARE LTD share price is currently at 1857.45, which is down by -10.45 from its previous closing. Today, the stock has fluctuated between 1852.85 and 1880.95. Over the past year, METROPOLIS HEALTHCARE LTD has achieved a return of 42.75 %. In the last month alone, the return has been 6.95 %.

METROPOLIS HEALTHCARE LTD Performance

Day Range

Low1852.85 High1880.95
1856.05

52 Week Range

Low 1209.25 High 1933.50
1856.05

Open Price

1865.05

Prev. Close

1867.90

Volume (Shares)

65006.00

Total traded value

1206.54

Upper Circuit

2054.65

Lower Circuit

1681.15

Note: The current prices & values are delayed, Login to your account for live updates.

METROPOLIS HEALTHCARE LTD Fundamentals


(Standalone)

Market Cap (Cr) 9512.12
PE Ratio (TTM) 77.14
Book Value / Share 193.68
Beta 0.92
ROE 15.65%
EPS (TTM) 24.21
Dividend Yield 0.43%
Net Profit Qtr (Cr) 26.70

METROPOLIS HEALTHCARE LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 269.41
Operating Expense 239.96
Net Profit 26.70
Net Profit Margin (%) 9.91
Earnings Per Share (EPS) 5.21
EBITDA 64.01
Effective Tax Rate (%) 22.89
Particulars SEP 2023 (Values in Cr)
Revenue 285.46
Operating Expense 244.97
Net Profit 31.28
Net Profit Margin (%) 10.95
Earnings Per Share (EPS) 6.11
EBITDA 69.48
Effective Tax Rate (%) 26.38
Particulars JUN 2023 (Values in Cr)
Revenue 256.29
Operating Expense 223.85
Net Profit 26.13
Net Profit Margin (%) 10.19
Earnings Per Share (EPS) 5.10
EBITDA 61.05
Effective Tax Rate (%) 25.83
Particulars MAR 2023 (Values in Cr)
Revenue 264.41
Operating Expense 225.22
Net Profit 39.93
Net Profit Margin (%) 15.10
Earnings Per Share (EPS) 7.80
EBITDA 76.85
Effective Tax Rate (%) 17.36
Particulars DEC 2022 (Values in Cr)
Revenue 264.55
Operating Expense 226.97
Net Profit 32.83
Net Profit Margin (%) 12.40
Earnings Per Share (EPS) 6.41
EBITDA 72.30
Effective Tax Rate (%) 26.02
Particulars MAR 2023 (Values in Cr)
Revenue 1066.04
Operating Expense 908.38
Net Profit 138.95
Net Profit Margin (%) 13.03
Earnings Per Share (EPS) 27.14
EBITDA 290.59
Effective Tax Rate (%) 22.35
Particulars MAR 2022 (Values in Cr)
Revenue 1157.01
Operating Expense 917.51
Net Profit 199.53
Net Profit Margin (%) 17.24
Earnings Per Share (EPS) 39.00
EBITDA 351.41
Effective Tax Rate (%) 26.51
Particulars MAR 2021 (Values in Cr)
Revenue 961.39
Operating Expense 731.56
Net Profit 182.65
Net Profit Margin (%) 18.99
Earnings Per Share (EPS) 35.88
EBITDA 293.58
Effective Tax Rate (%) 24.56
Particulars MAR 2020 (Values in Cr)
Revenue 665.31
Operating Expense 530.10
Net Profit 112.05
Net Profit Margin (%) 16.84
Earnings Per Share (EPS) 22.32
EBITDA 177.40
Effective Tax Rate (%) 19.95
Particulars MAR 2019 (Values in Cr)
Revenue 581.21
Operating Expense 452.53
Net Profit 101.46
Net Profit Margin (%) 17.45
Earnings Per Share (EPS) 20.32
EBITDA 165.15
Effective Tax Rate (%) 31.99
Particulars MAR 2023 (Values in Cr)
Book Value / Share 192.97
ROE % 15.30
ROCE % 17.23
Total Debt to Total Equity 0.34
EBITDA Margin 26.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share 173.18
ROE % 26.96
ROCE % 30.24
Total Debt to Total Equity 0.31
EBITDA Margin 31.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 138.23
ROE % 29.81
ROCE % 35.83
Total Debt to Total Equity 0.15
EBITDA Margin 30.24
Particulars MAR 2020 (Values in Cr)
Book Value / Share 103.40
ROE % 30.60
ROCE % 39.47
Total Debt to Total Equity 0.09
EBITDA Margin 28.59
Particulars MAR 2019 (Values in Cr)
Book Value / Share 83.41
ROE % 29.67
ROCE % 44.19
Total Debt to Total Equity 0.02
EBITDA Margin 27.69
Particulars MAR 2023 (Values in Cr)
Book Value / Share 182.78
ROE % 15.65
ROCE % 17.19
Total Debt to Total Equity 0.36
EBITDA Margin 27.69
Particulars MAR 2022 (Values in Cr)
Book Value / Share 164.00
ROE % 26.53
ROCE % 29.41
Total Debt to Total Equity 0.32
EBITDA Margin 30.80
Particulars MAR 2021 (Values in Cr)
Book Value / Share 130.06
ROE % 31.03
ROCE % 37.36
Total Debt to Total Equity 0.14
EBITDA Margin 30.91
Particulars MAR 2020 (Values in Cr)
Book Value / Share 101.20
ROE % 27.96
ROCE % 34.60
Total Debt to Total Equity 0.08
EBITDA Margin 30.87
Particulars MAR 2019 (Values in Cr)
Book Value / Share 82.79
ROE % 26.03
ROCE % 37.84
Total Debt to Total Equity 0.02
EBITDA Margin 28.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 93.19
Total Assets 1501.60
Total Liabilities 1501.60
Total Equity 990.71
Share Outstanding 51210664
Price to Book Ratio 6.83
Return on Assets (%) 9.51
Return on Capital (%) 13.36
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 166.93
Total Assets 1530.29
Total Liabilities 1530.29
Total Equity 888.16
Share Outstanding 51172119
Price to Book Ratio 12.42
Return on Assets (%) 13.99
Return on Capital (%) 18.68
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 419.69
Total Assets 1004.41
Total Liabilities 1004.41
Total Equity 708.06
Share Outstanding 51116813
Price to Book Ratio 17.23
Return on Assets (%) 18.22
Return on Capital (%) 25.86
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 210.47
Total Assets 752.23
Total Liabilities 752.23
Total Equity 525.15
Share Outstanding 50630566
Price to Book Ratio 12.71
Return on Assets (%) 16.92
Return on Capital (%) 24.25
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 80.23
Total Assets 552.64
Total Liabilities 552.64
Total Equity 419.96
Share Outstanding 50178680
Price to Book Ratio 0.00
Return on Assets (%) 21.74
Return on Capital (%) 27.46
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 42.94
Total Assets 1434.29
Total Liabilities 1434.29
Total Equity 936.01
Share Outstanding 51210664
Price to Book Ratio 6.83
Return on Assets (%) 9.68
Return on Capital (%) 13.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 115.35
Total Assets 1458.54
Total Liabilities 1458.54
Total Equity 839.20
Share Outstanding 51172119
Price to Book Ratio 12.42
Return on Assets (%) 13.68
Return on Capital (%) 18.18
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 380.62
Total Assets 939.12
Total Liabilities 939.12
Total Equity 664.80
Share Outstanding 51116813
Price to Book Ratio 17.23
Return on Assets (%) 19.44
Return on Capital (%) 27.47
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 132.00
Total Assets 688.29
Total Liabilities 688.29
Total Equity 512.38
Share Outstanding 50630566
Price to Book Ratio 12.71
Return on Assets (%) 16.27
Return on Capital (%) 21.87
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 25.80
Total Assets 527.64
Total Liabilities 527.64
Total Equity 415.40
Share Outstanding 50178680
Price to Book Ratio 0.00
Return on Assets (%) 19.22
Return on Capital (%) 23.44
Particulars MAR 2023 (Values in Cr)
Net Income 187.50
Cash from Operations 298.66
Cash from Investing 46.79
Cash from Financing -292.32
Net change in Cash 1.55
Free Cash Flow 351.30
Particulars MAR 2022 (Values in Cr)
Net Income 293.35
Cash from Operations 335.78
Cash from Investing -737.57
Cash from Financing 162.52
Net change in Cash -321.77
Free Cash Flow 366.44
Particulars MAR 2021 (Values in Cr)
Net Income 244.32
Cash from Operations 305.86
Cash from Investing 61.70
Cash from Financing -32.69
Net change in Cash 278.03
Free Cash Flow 334.13
Particulars MAR 2020 (Values in Cr)
Net Income 168.73
Cash from Operations 279.42
Cash from Investing -104.83
Cash from Financing -55.32
Net change in Cash 54.84
Free Cash Flow 315.63
Particulars MAR 2019 (Values in Cr)
Net Income 186.55
Cash from Operations 157.55
Cash from Investing 35.34
Cash from Financing -118.14
Net change in Cash 7.34
Free Cash Flow 177.11
Particulars MAR 2023 (Values in Cr)
Net Income 178.94
Cash from Operations 281.78
Cash from Investing 46.72
Cash from Financing -287.86
Net change in Cash -3.40
Free Cash Flow 330.32
Particulars MAR 2022 (Values in Cr)
Net Income 271.54
Cash from Operations 320.21
Cash from Investing -738.21
Cash from Financing 171.97
Net change in Cash -322.19
Free Cash Flow 357.15
Particulars MAR 2021 (Values in Cr)
Net Income 242.12
Cash from Operations 291.29
Cash from Investing 59.41
Cash from Financing -31.26
Net change in Cash 264.37
Free Cash Flow 317.83
Particulars MAR 2020 (Values in Cr)
Net Income 139.99
Cash from Operations 203.74
Cash from Investing -51.12
Cash from Financing -46.37
Net change in Cash 58.63
Free Cash Flow 226.48
Particulars MAR 2019 (Values in Cr)
Net Income 149.18
Cash from Operations 108.16
Cash from Investing -4.35
Cash from Financing -63.96
Net change in Cash -11.89
Free Cash Flow 127.44
Company Name Price P/E P/B Market Cap 52 Week Low/High
METROPOLIS HEALTHCARE LTD 1867.55 76.70 9.14 9567.24 1209.25 / 1935.00
APOLLO HOSPITALS ENTER. L 5931.30 108.22 13.11 85282.99 4410.05 / 6871.30
FORTIS MALAR HOSPITALS LIMITED 72.93 0.00 2.30 136.68 44.00 / 107.94
SHREE PACETRONIX LTD. 215.15 19.94 6.91 77.44 121.60 / 391.90
TRANSGENE BIOTEK LTD. 6.47 0.00 4.41 49.02 3.57 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
METROPOLIS HEALTHCARE LTD 1867.55 77.14 9.64 9567.24 1209.25 / 1935.00
APOLLO HOSPITALS ENTER. L 5931.30 85.40 11.69 85282.99 4410.05 / 6871.30
Metropolis Healthcare Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 34.43 95.64 144.24 25.72 19.50 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 4022.10 27.83 5.63 4400.18 1968.15 / 4271.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1827.00
  • 26 Days 1789.40
  • 10 Days 1816.00
  • 50 Days 1741.60
  • 12 Days 1811.20
  • 100 Days 1712.40
  • 20 Days 1797.30
  • 200 Days 1438.20
1838.47
PIVOT
First Resistance 1871.88
Second Resistance 1893.52
Third Resistance 1926.93
First Support 1816.83
Second Support 1783.42
Third Support 1761.78
RSI 62.98
MACD 21.82
Commodity Channel Index (CCI) 160.60
ADX 16.71
Williams % R -10.00

Over 1 Month

down

6.95

Over 3 Months

down

4.59

Over 6 Months

down

16.24

Over 1 Year

down

42.75

Over 3 Years

down

-6.79

Over 5 Years

down

15.09

METROPOLIS HEALTHCARE LTD Future

Future: Price

30 May
1860.45
27 Jun
1820.00
25 May
0 100 200 300 400 500 600

Discount/Premium

30 May
10.20
27 Jun
-30.25
25 May
0 1 2 3 4 5 6 7

Active Calls

1900.0
638
1800.0
271
1840.0
257
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

1600.0
209
1800.0
195
1840.0
123
25 Jul
0 500 1000 1500 2000 2500

METROPOLIS HEALTHCARE LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
10.12
Promoter Holdings
49.66
FII
18.9
DII
21.3
Promoter Shares(Pledge Percentage)
2.36
Name Category Shares Shares%
Metz Advisory Llp Shareholding of Promoter and Promoter Group 1.5691216E7 30.63
Duru Shah Family Trust Shareholding of Promoter and Promoter Group 4964026.0 9.69
Hdfc Mutual Fund - Hdfc Focused 30 Fund Public Shareholding 3406307.0 6.65
Uti Large Cap Fund Public Shareholding 2793325.0 5.45
Sushil Shah Family Trust Shareholding of Promoter and Promoter Group 2558187.0 4.99
Franklin India Smaller Companies Fund Public Shareholding 1529763.0 2.99
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund Public Shareholding 1313455.0 2.56
Sushil Kanubhai Shah Shareholding of Promoter and Promoter Group 1282058.0 2.5
J P Morgan Funds Public Shareholding 1137042.0 2.22
Sbi Life Insurance Co. Ltd Public Shareholding 1096700.0 2.14
Quant Mutual Fund - Quant Small Cap Fund Public Shareholding 950468.0 1.86
Duru Sushil Shah Shareholding of Promoter and Promoter Group 765659.0 1.49
Caisse De Depot Et Placement Du Quebec - First Sentier Investors International Im Limited Public Shareholding 740148.0 1.44
Jpmorgan Indian Investment Trust Plc Public Shareholding 709652.0 1.39
The Scottish Oriental Smaller Companies Trustplc Public Shareholding 609831.0 1.19
Aditya Birla Sun Life Trustee Private Limited A/c Aditya Birla Sun Life Flexi Cap Fund Public Shareholding 604745.0 1.18
Fssa Indian Subcontinent Fund As Sub Fund Of First Sentier Investors Global Umbrella Fund Plc Public Shareholding 585337.0 1.14
Ameera Sushil Shah Shareholding of Promoter and Promoter Group 181845.0 0.35

METROPOLIS HEALTHCARE LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-11-17 4.0 Interim 2023-11-17 Equity shares 2023-02-23 8.0 Interim 2023-02-23 Equity shares 2022-02-21 8.0 Interim 2022-02-22 Equity shares 2021-02-17 8.0 Interim 2021-02-19 Equity shares 2020-02-13 8.0 Interim 2020-02-15 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About METROPOLIS HEALTHCARE LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by METROPOLIS HEALTHCARE LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Metropolis Healthcare Ltd?

Answer Field

The share price of Metropolis Healthcare Ltd for NSE is ₹ 1857.45 and for BSE is ₹ 1852.9.

What is the Market Cap of Metropolis Healthcare Ltd?

Answer Field

The market cap of Metropolis Healthcare Ltd for NSE is ₹ 9,512.12 Cr. and for BSE is ₹ 9,488.82 Cr. as of now.

What is the 52 Week High and Low of Metropolis Healthcare Ltd?

Answer Field

The 52 Week High and Low of Metropolis Healthcare Ltd for NSE is ₹ 1933.50 and ₹ 1209.25 and for BSE is ₹ 1935.00 and ₹ 1209.25.

How to Buy Metropolis Healthcare Ltd share?

Answer Field

You can trade in Metropolis Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Metropolis Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 42.75%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader